| Predicted Trait | |
| Reported Trait | Type 2 diabetes (T2D) |
| Mapped Trait(s) | type 2 diabetes mellitus (MONDO_0005148) |
| Score Construction | |
| PGS Name | PRSdiabetes |
| Development Method | |
| Name | Genome-wide significant SNPs |
| Parameters | p<0.2 |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 42,845 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000697 |
| Citation (link to publication) | Takase M et al. J Atheroscler Thromb (2023) |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST007847 Europe PMC: 30718926 |
191,764 individuals | East Asian | BBJ |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| — | 1,936 individuals | East Asian | TMM | Diabetes was defined as non-fasting glucose ≥ 200 mg/dL, HbA1c ≥ 6.5% (48 mmol/mol), and/or self-reported treatment for diabetes | — | — | — | — |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM022294 | PSS011905| East Asian Ancestry| 7,745 individuals |
PGP000697 | Takase M et al. J Atheroscler Thromb (2023) |
Reported Trait: Prevalent diabetes | — | — | Odds ratio (OR, high vs low PGS tertile): 3.16 [2.45, 4.12] | Age, sex, 6 PCs | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS011905 | Diabetes was defined as non-fasting glucose ≥ 200 mg/dL, HbA1c ≥ 6.5% (48 mmol/mol), and/or self-reported treatment for diabetes | — | 7,745 individuals, 23.7 % Male samples |
Mean = 57.3 years Sd = 13.4 years |
East Asian | — | TMM | — |